Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.021\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCOc1ccc(Oc2nc(NCC(C)C)nc(N(C)C)n2)nn1
[b] CC(C)CCn1c(N)c(C(=O)OCC2CCCO2)c2nc3ccccc3nc21
Answer: a. CCOc1ccc(Oc2nc(NCC(C)C)nc(N(C)C)n2)nn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(Oc2nc(NCC(C)C)nc(N(C)C)n2)nn1
CCOc1ccc(Oc2nc(NCC(C)C)nc(N(C)C)n2)nn1
6-(6-ethoxypyridazin-3-yl)oxy-2-N,2-N-dimethyl-4-N-(2-methylpropyl)-1,3,5-triazine-2,4-diamine